Fully Bioresorbable Peripheral Drug-Eluting Stent System
PeriSorb® SFA is a peripheral bioresorbable drug-eluting stent manufactured by the proprietary MASE technology. The product has been approved by NMPA for the registration clinical trials currently ongoing in multiple medical centers in China.
If you want to get more product information, welcome to contact us
Fully Bioresorbable Peripheral Drug-Eluting Stent System
Graphic Details
PeriSorb® is a fully bioresorbable drug-eluting stent system for treating superficial femoral artery disease. The stent is manufactured by the company's proprietary Multi-Axial Scaffold Extrusion (MASE) technology with the advantages of high efficiency and cost effectiveness. The product has been undergoing the registration clinical trials (FIM and RCT) approved by NMPA.
Product Features
● New and improved biodegradable stent material (PLCL) for better fatigue resistance and faster degradation rate
● Patented closed-cell stent design with excellent flexibility and structural stability
● Abluminal drug delivery
Product Specifications
Stent diameter: 4mm~6mm
Stent length: 36mm~76mm